|
⚲
|
| Keyboard |
| Lacey John III
✚
|
|
|---|---|
| CIK # | 0001739761 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001739761] | |
| 4 | [0001739761] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Provectus Biopharmaceuticals Inc | |
| Lacey John III |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Provectus Biopharmaceuticals Inc PVCT
Stock Options (Right to Buy) · derivative
|
2024-12-02 | Grant | 775,082 | $0.00 | |
|
Provectus Biopharmaceuticals Inc PVCT
Series D-1 Convertible Preferred Stock · derivative
|
2024-09-30 | Grant | 179,592 | $0.00 | |
|
Provectus Biopharmaceuticals Inc PVCT
Common Stock
|
2020-11-10 | Grant | 100,000 | $0.00 | |
|
Provectus Biopharmaceuticals Inc PVCT
Stock Options (Right to Buy) · derivative
|
2020-11-10 | Grant | 100,000 | $0.00 |